X

Download Flow Cytometry leukemia PowerPoint Presentation

SlidesFinder-Advertising-Design.jpg

Login   OR  Register
X


Iframe embed code :



Presentation url :

Home / Health & Wellness / Health & Wellness Presentations / Flow Cytometry leukemia PowerPoint Presentation

Flow Cytometry leukemia PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

PowerPoint is the world's most popular presentation software which can let you create professional Flow Cytometry leukemia powerpoint presentation easily and in no time. This helps you give your presentation on Flow Cytometry leukemia in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this Flow Cytometry leukemia powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by onlinesearch in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

About This Presentation

Slide 1 - 3rd International ELN Workshop: Standardization of Flow Cytometry in MDS London, Greenwich 4-6 November 2010 a.a. van de loosdrecht, chair r. ireland, co-chair update ELNet wp8; ASH Orlando, December 4, 2010 and ELNet WP conference, Mannheim, February 1, 2011
Slide 2 - 12 countries; 28 participants; in- and outside Europe Austria: P. Valent France: MC Bene, J. Feuillard Germany: W. Kern Great Britain: R. Ireland, U. Johansson, M. Cullen, G. Mufti, T. Minle, S. Kordasti Italy: M. della Porta [absent] Netherlands: C. Alhan, A.A. van de Loosdrecht, J te Marvelde, V. van de Velden, TM Westers, B. Moshaver, T deWitte Spain: [absent] Sweden: A. Porwit Greece: K. Psarra Japan: K. Ogata USA: D. Wells, M. Loken, J Cutler Australia: K. Burbury 3rd International ELN Workshop: Standardization of Flow Cytometry in MDS London, Greenwich 4-6 November 2010 a.a. van de loosdrecht, chair r. ireland, co-chair
Slide 3 - define minimal flow cytometric criteria to analyse MDS  ELN 2011 [2 consensus documents: rationale/technical] Define: role of FCM: Diagnosis Prognosis predictive value for R/ [emerging new drugs] disease monitoring Goal:
Slide 4 - Proposed antigens of importance in FCM in MDS: ELN consensus 2009 ELN consensus document MDS and flow cytometry: van de Loosdrecht, ELN members WP8, et al., Haematologica 2009;94:1124-1134
Slide 5 - Overview of some recommended flow cytometric analyses of subsets in the BM by the ELNet; London 2010
Slide 6 - Analysis of a minimized multiparameter panel % CD34+ myeloblasts % CD34+ B cells of total CD34+ CD45 expression of Ly vs. Myeloblasts SSC ratio of CD10- neutrophils vs. Ly Ogata et al, Blood, 2006; Ogata/Della Porta, Haematologica, 2009 Della Porta, et al., 2011 (to be submitted); Japan/Italy/Netherlands/Sweden/USA/UK
Slide 7 - n=45 n=22 n=58 n=24 n=45 n=34 n=31 n=37 Analysis of myelomonopoiesis Wells et al., Blood, 2003; Van de Loosdrecht and Westers et al., Blood, 2008 Alhan et al.; unpublished data set june 2010 Chu et al., personal communication ASH2010; Kern et al., Cancer 2010 severe mild normal April 1, 2010
Slide 8 - In part published: Loosdrecht AA van de, Westers TM et al., Blood 2008;111 Chu et al., personal communication; ASH#2010 myeloblasts either: CD5 (o), CD7 (o) or CD56 (o) positive FCSS is related to transfusion-dependency and progression to AML low/int-I risk MDS
Slide 9 - 1. Flow cytometry is recognized in the diagnostic and prognostic work-up of patients with cytopenia (ELN-2009; ELN-2011) 2. An ELN consensus guideline for flow cytometry in MDS is now available (ELN, Haematologica, 2009; updated 2011; to be submitted) 3. Rationale for clinical use of flow cytometry is defined (ELN-2011: to be submitted) Clinical impact of flow cytometry in MDS
Slide 10 - Perspectives: 2011 Submission 1q/2011: 3 ELN consensus documents 4th international ELN meeting in Pavia Italy: co-chair Matteo dellaPorta (October 2011)  diagnostics  FCSS-revised  erythroid-lineage  incorporate software tools for analysis/statistics  clinical reporting